$34.03
0.41% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US8954361031
Symbol
TY

Tri-Continental Corp. Stock price

$34.03
+0.93 2.81% 1M
+3.23 10.49% 6M
+5.20 18.04% YTD
+6.47 23.48% 1Y
-1.43 4.04% 3Y
+5.95 21.18% 5Y
+12.47 57.87% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.14 0.41%
ISIN
US8954361031
Symbol
TY
Sector

Key metrics

Market capitalization $1.76b
Enterprise Value $1.76b
EV/Sales (TTM) EV/Sales 12.41
P/S ratio (TTM) P/S ratio 12.37
Dividend yield 9.88%
Last dividend (FY24) $3.36
Revenue growth (TTM) Revenue growth 256.64%
Revenue (TTM) Revenue $141.91m
EBIT (operating result TTM) EBIT $281.75m
EPS (TTM) EPS $5.41
Show more

Is Tri-Continental Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Financial data from Tri-Continental Corp.

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
142 142
257% 257%
100%
- Direct Costs 7.50 7.50
4% 4%
5%
134 134
313% 313%
95%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
282 282
69% 69%
199%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 282 282
69% 69%
199%
Net Profit 282 282
69% 69%
199%

In millions USD.

Don't miss a Thing! We will send you all news about Tri-Continental Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tri-Continental Corp. Stock News

Neutral
Business Wire
5 months ago
MINNEAPOLIS--(BUSINESS WIRE)--Tri-Continental Corporation (the “Corporation”) (NYSE: TY) today held its 94th Annual Meeting of Stockholders (the “Meeting”) in Minneapolis, Minnesota. Stockholders voted in favor of the recommendations of the Corporation's Board of Directors (the “Board”) on each of two proposals at the Meeting. Specifically, Stockholders re-elected Directors Kathleen Blatz, Pame...
Neutral
Business Wire
5 months ago
BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology, oncology and immunology, today announced completion of enrollment for two clinical trials evaluating its ropeginterferon...
Positive
Seeking Alpha
6 months ago
Tri-Continental Corporation offers exposure to domestic equity securities with a 3.82% yield, lower than peers but higher than American common equity indices. The TY closed-end fund's shares have gained 14.81% over the past five years, underperforming the S&P 500 but outperforming investment-grade bonds. The fund's portfolio primarily consists of common stocks, with an emphasis on high-yielding...

Company Profile

Tri-Continental Corp. is a diversified, closed-end management investment company, which invests primarily for the longer term. Its objective is to produce future growth of both capital and income while providing reasonable current income. The company was founded on January 14, 1929 and is headquartered in Boston, MA.

Head office United States
CEO Christopher Petersen
Founded 1929
Website www.columbiathreadneedleus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today